ArticleCancers2022

Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors.

Hirofumi Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.